Trial Profile
A Phase II Study Of Single Agent Depsipeptide (FK228) In Breast Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Romidepsin (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 18 Aug 2005 New trial record.